By controlling the expression of several angiogenic mediators, including the vascular endothelial growth factor receptor-2 (VEGFR-2), this transcription factor promotes angiogenesis, tumor growth, and metastasis, all of which contribute to worsening patient outcomes [3]. The gene discussed is KDR; the disease is neoplasm.